The Alzheimer's Biomarker Revolution: How it Will Transform the Diagnosis and Management of Alzheimer's Disease

Sep 23, 2021 Medicine

The Alzheimer's Biomarker Revolution: How it Will Transform the Diagnosis and Management of Alzheimer's Disease

Description

Due to the ongoing COVID-19 pandemic, this program will be offered virtually only.

MemoryCare and MAHEC welcome internationally recognized speaker, Dr. Jason Karlawish, on Thursday evening, September 23rd, from 5:30 - 7:00 pm. Dr. Kalawish is a dementia expert, geriatrician, bioethicist, researcher, writer, and professor at Penn Memory Center in Philadelphia, PA. Dr. Kalawish will discuss the advances in the rapidly evolving field of dementia bio-markers on the diagnosis and management of Alzheimer's disease and other dementias.

Alzheimer’s disease is the most common type of disabling progressive cognitive impairment in older adults, affecting one in nine people over 65 and impacting over 11.2 million family caregivers in the U.S. Alzheimer’s disease is now understood as a continuum of pathologic changes that begin 10 – 20 years prior to symptom onset. Advances in biomarker research (Abeta 42, phospho-tau, imaging scan evidence of neurodegeneration), as well as genetic risk markers are allowing researchers to study potentially therapeutic agents in pre-clinical and early symptomatic stages when preservation of brain function might be most effective.

Dr. Karlawish will update clinicians on the role of biomarkers in dementia diagnosis and monitoring so providers may engage in thoughtful and informed conversation with patients and their families around the risk and benefits of such testing in relation to personal value systems. Providers will gain understanding on biomarkers potential utility in confirming a suspected diagnosis and strategies to assist with addressing considerations and questions regarding defining dementia risk through genetic and biomarker testing after a diagnosis in the family. 

Book Discount
The Problem of Alzheimer's may be purchased from the local bookstore, Malaprop's, at a 10% discount! In-store request the "Book Club" discount or online use the coupon code "MEMORYCARE" at checkout.

This project is supported by funds from the Bureau of Health Professions (BHPr), Health Resources and Services Administration (HRSA), Department of Health and Human Services (DHHS) under grant number # 2U1QHP28734 Carolina Geriatric Workforce Enhancement Program. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by the BHPr, HRSA, DHHS or the U.S. Government. The Center for Aging and Health, Carolina Geriatric Workforce Enhancement Program also provided support for this activity.

CGEC

Memory Care


Target Audience

Physicians, Advanced Practice Providers, Nurses, Social Workers, Mental Health Providers and others interested in Alzheimer's care and research

Objectives

  • Describe the continuum of Alzheimer’s Disease (AD) from pre-clinical AD to mild cognitive impairment due to AD to AD dementia phase.
  • Employ knowledge of clinical biomarkers (e.g. CSF a-beta/tau, MRI, FDG- and Amyloid-PET) in the evaluation of neurodegenerative dementias to differentiate AD and non-AD processes.
  • Guide dementia caregivers through an ethical decision-making process regarding quality of life, medico-legal, and end of life issues for a loved one with a disease of autonomy such as Alzheimer’s disease.

Faculty

  • Jason Karlawish, MD

Sessions

The Alzheimer's Biomarker Revolution: How it Will Transform the Diagnosis and Management of Alzheimer's Disease - Live Webinar
9/23 5:30 PM–7:00 PM

Credits

.200 CEU

The Mountain Area Health Education Center designates this entire continuing education activity as meeting the criteria for 0.20 CEUs as established by the National Task Force on the Continuing Education Unit.

1.500 Contact Hours

MAHEC designates this continuing education activity as meeting the criteria for 1.50 Contact Hours.

1.500 Contact Hours

Nurse Practitioners

Nurse Practitioners: MAHEC designates this continuing education activity as meeting the criteria for 1.50 contact hours.

1.500 Nursing Contact Hours

Participants must attend the entire activity to receive credit.

1.50 Nursing Contact Hours Activity # AP 008-1910 Mountain Area Health Education Center (MAHEC) is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

1.500 CME for Physician Assistants

Physician Assistants: AAPA accepts certificate of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician Assistants may receive a maximum of 1.50 hours of Category 1 credit for completing this program.

1.500 AMA PRA Category 1 Credit TM

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the North Carolina Medical Society (NCMS) through the joint providership of the Mountain Area Health Education Center (MAHEC) and Memory Care. MAHEC is accredited by the NCMS to provide continuing medical education for physicians. Credit Designation: MAHEC designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. "

Fees

$40.00 Registration Fee
Applies 9/17/21–9/23/21
Register Brochure / Registration Form